Acutaas Chemicals to Host Q4 FY26 Earnings Call on April 30

Acutaas Chemicals Limited will host an earnings conference call on Thursday, April 30, 2026, at 5:30 PM IST to present its audited standalone and consolidated financial results for the fourth quarter (Q4FY26) and the full fiscal year (FY26). Investors are focused on the company's performance and its new growth engines.

Key Details of the Announcement

The company has scheduled this call for shareholders and analysts to present and discuss its Audited Standalone & Consolidated Financial Results for Q4FY26 and the full fiscal year FY26. The event is set for Thursday, April 30, 2026, starting at 5:30 PM IST.

Why This Matters

Earnings calls are key events where management offers a detailed look at financial performance, strategic plans, and future outlook. For investors, these calls provide direct insights from leadership about the company's direction. Acutaas Chemicals is holding this call after a strong Q3 FY26, which saw significant revenue and profit increases, along with better margins. Investors will be looking to see if this positive trend continued in Q4.

Company Performance and Strategy

Acutaas Chemicals, previously Ami Organics, has shown strong performance recently. In Q3 FY26, revenue grew 43% year-on-year to ₹393.2 crore, and Profit After Tax (PAT) surged 133.7% year-on-year to ₹106.2 crore. The company also achieved record margins, with EBITDA at 38.3% and gross margin at 57%, thanks to a better product mix and operational efficiencies.

The company is diversifying into battery chemicals and semiconductor chemicals, complementing its core pharmaceutical intermediates and CDMO business. Acutaas Chemicals is the sole Indian manufacturer of semiconductor-grade photoresist chemicals and has a joint venture in this area. Management has raised its FY26 revenue growth guidance to approximately 30%. Additionally, a Goods and Services Tax (GST) demand of ₹15.44 lakhs was resolved favorably in January 2026, with the appeals authority dropping the case.

What to Anticipate from the Call

This announcement signals the upcoming release of Acutaas Chemicals' full-year financial results. The earnings call will provide investors and analysts with a deeper understanding of the company's operational performance and its strategic growth drivers. Management will also share their views on market conditions, the competitive landscape, and future growth prospects, offering a platform to address investor questions directly.

Risks to Watch

This announcement did not highlight any new significant risks. The company recently resolved a past GST matter. Investors will likely seek management's commentary on any emerging industry challenges or competitive pressures during the call.

Peer Comparison

Acutaas Chemicals competes in the specialty chemicals and pharmaceutical intermediates sector. Its key peers include Aarti Industries Ltd, Navin Fluorine International Ltd, Sudarshan Chemical Industries Ltd, and Atul Ltd. While Aarti Industries and Navin Fluorine are established players in diversified chemical segments, Acutaas is building a niche in high-growth areas like semiconductor and battery chemicals, alongside its pharma CDMO operations. The company's strong Q3 FY26 performance, with 133.7% PAT growth and upgraded guidance, indicates it is currently outperforming on growth.

Q3 FY26 Performance Snapshot

• Revenue: ₹393.2 crore
• Profit After Tax (PAT): ₹106.2 crore
• EBITDA margin: 38.3%
  (Note: Standalone/Consolidated status not specified for these figures)

What to Track Next

Investors should listen to the earnings conference call on April 30, 2026, for management's detailed commentary. Key areas to monitor include the Q4 FY26 and full-year FY26 financial results, management's guidance for FY27 on revenue growth, margins, and capital expenditure. Also, track the progress and revenue contribution from the new growth segments (battery and semiconductor chemicals) and the CDMO business, as well as the company's ability to maintain its strong growth and margin profile.